SCHEMBL6207937

SCHEMBL6207937

[CH2]S(=O)(=O)/C=C/c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 0.55
LMNA P02545 3/20 0.55
NFE2L2 Q16236 2/20 0.55
MAOB P27338 1/20 0.48
KMT2A Q03164 2/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 2/20 0.46
TRPA1 O75762 1/20 0.46
ALDH1A1 P00352 1/20 0.46
ALOX5 P09917 1/20 0.46
HSP90AA1 P07900 2/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC3 O15379 1/20 0.44
TNKS O95271 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207941 1.00 PPARG (0.55) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL587895 0.82 PPARG (0.57) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL1194569 0.82 PPARG (0.57) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL3730162 0.82 PPARG (0.57) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL19155588 0.82 PPARG (0.57) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL11807237 0.80 PPARG (0.55) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL15845143 0.80 PPARG (0.55) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL21647828 0.80 PPARG (0.55) PPARGLMNANFE2L2MAOBKMT2A
SCHEMBL10622974 0.79 PPARG (0.50) PPARGLMNANFE2L2MAOBKMT2A
Formaldehyde SCHEMBL10338470 0.79 PPARG (0.50) PPARGLMNANFE2L2MAOBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709375-B1 Therapeutic heterocycles ASTRAZENECA AB (SE) 2005-05-18 EP disclosed
US-6147083-A NOVEL SUBSTITUTED 1,2-ETHANEDIAMINE DERIVATIVES WHICH ANTAGONIZE THE PHARMACOLOGICAL ACTIONS OF THE ENDOGENOUS NEUROPEPTIDE TACHYKININS KNOWN AS NEUROKININS, USEFUL FOR THE TREATMENT OF ASTHMA, ETC. ZENECA LIMITED (GB) 2000-11-14 US disclosed
US-5998444-A ANTIASTHMA AGENTS; NEUROKININ ANTAGONIST ZENECA LTD. (GB) 1999-12-07 US disclosed
US-5710169-A NEUROKININ ANTAGONISTS; ANTIHISTAMINES, BRONCHODILATOR AGENTS; ASTHMA ZENECA LIMITED (GB) 1998-01-20 US disclosed
EP-0709375-A2 Therapeutic heterocycles ZENECA LIMITED (GB) 1996-05-01 EP disclosed